Table 1.
Patient VAS (0–10) | “Microneedling plus topical minoxidil” group (N = 31) | “Minoxidil alone” group (N = 29) |
---|---|---|
0 | 1 (3.2%) | 7 (24.1%) |
1 | 3 (9.7%) | 11 (37.9%) |
2 | 6 (19.4%) | 9 (31%) |
3 | 11 (35.5%) | 2 (6.9%) |
4 | 6 (19.4%) | 0 |
5 | 4 (12.9%) | 0 |
Patient VAS (0–10) | “Microneedling plus topical minoxidil” group (N = 31) | “Minoxidil alone” group (N = 29) |
---|---|---|
0 | 1 (3.2%) | 7 (24.1%) |
1 | 3 (9.7%) | 11 (37.9%) |
2 | 6 (19.4%) | 9 (31%) |
3 | 11 (35.5%) | 2 (6.9%) |
4 | 6 (19.4%) | 0 |
5 | 4 (12.9%) | 0 |